Ances honored by Down syndrome society
Beau M. Ances, MD, PhD, the Daniel J. Brennan Professor of Neurology at the School of Medicine, recently received the Shining Star Award from the Down Syndrome Association of Greater St. Louis.
COVID-19 survivors face increased mental health risks up to a year later
People who have had mild or serious COVID-19 infections have a significantly higher chance of experiencing mental health problems, according to new research from the Washington University School of Medicine and the Veterans Affairs St. Louis Health Care System.
Antibodies improve in quality for months after COVID-19 vaccination
Antibodies elicited by COVID-19 vaccination become steadily more powerful for at least six months after vaccination, according to a study by researchers at Washington University School of Medicine that involved the Pfizer-BioNTech COVID-19 vaccine.
A debt of gratitude
Health-care workers at the Washington University School of Medicine have contributed greatly to regional and world health during the pandemic, and we owe them so much appreciation.
Smoothing the path
Medical trailblazer Victoria Fraser, MD, focuses on creating equity in academic medicine.
Diabetes, metabolic syndrome in mice treated with novel class of compounds
Researchers at Washington University School of Medicine have shown, in mice, that a new class of compounds they developed can improve several aspects of metabolic syndrome. Such conditions often lead to cardiovascular disease, the leading cause of death worldwide.
Six innovators named National Academy of Inventors senior members
Five researchers from the School of Medicine and one from the McKelvey School of Engineering have been named senior members of the National Academy of Inventors.
Boyer elected to orthopedic surgery board
Martin I. Boyer, MD, the Carol B. and Jerome T. Loeb Professor of Orthopaedic Surgery at the School of Medicine, has been named a director-elect for the American Board of Orthopaedic Surgery.
Washington University participates in clinical trial of Moderna omicron booster
Washington University School of Medicine is participating in a nationwide phase 2 clinical trial to evaluate whether an investigational omicron-specific booster of the Moderna COVID-19 vaccine is safe and capable of eliciting a strong immune response.
Researchers unravel omicron’s secrets to better understand COVID-19
In two recent studies, researchers at Washington University School of Medicine found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants — at least in rodents — but that many antibody-based therapies may not be effective against it.
View More Stories